Riskpilot← Back to searchSign inGet full accessAvanzakliniken AB
ABActiveOrg 5567440689Storgatan 43General medical practice activities · NACE 8621Est. 20073 employees
Revenue 2025
SEK 5,8M
+4% vs 2024
EBITDA margin
25.3%
+37% vs 2024
Equity ratio
53.8%
Financial strength
Net profit 2025
SEK 956K
+52% vs 2024
| Revenue | SEK 5,8M | +4% |
| EBITDA | SEK 1,5M | +37% |
| Net profit | SEK 956K | +52% |
| Total assets | SEK 6,1M | +12% |
| Equity | SEK 3,3M | -1% |
| Employees | 3 | — |
Legal name
Avanzakliniken AB
Org number
5567440689
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 november 2007
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Basanic Taltavull, Brizita Birgitta
Company purpose
Bolaget skall bedriva medicinsk hudvård, tillhandahålla, utbilda och utföra tjänster inom estetisk behandling, injektionsbehandling, försäljning av hudvårdsprodukter, försäljning av medicinsk apparatur samt därmed förenlig verksamhet.
Address
Storgatan 43
Phone
+4635121821
Email
info@birgittakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 689 | 4 877 | 5 204 | 5 589 | 5 786 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 042 | 900 | 521 | 1 073 | 1 466 |
| Depreciation & amort. | −90 | −178 | −186 | −216 | −150 |
| EBIT | 952 | 722 | 335 | 857 | 1 316 |
| Net financials | −1 | — | 1 | 2 | — |
| Profit before tax | 864 | 701 | 551 | 810 | 1 216 |
| Tax | −183 | −150 | −129 | −179 | −260 |
| Net profit | 681 | 551 | 422 | 631 | 956 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 804 | 4 995 | 4 741 | 5 457 | 6 120 |
| Equity | 2 731 | 2 782 | 2 705 | 3 335 | 3 291 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 441 | 560 | 599 | 635 | 1 241 |
| Total debt | 441 | 560 | 599 | 635 | 1 241 |
EBITDA margin
25.3%
This company
15.8%
Market median
+60% vs market
20212025
Equity ratio
53.8%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
29.0%
This company
18.4%
Market median
+58% vs market
20212025
Net profit margin
16.5%
This company
8.1%
Market median
+104% vs market
20212025
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20212025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
| Audit | 2020 – 2024 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Avanzakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Christer Viking Andersson | Audit | 0 companies |
| Stefan Johan Andreas Nilsson | Chief Auditor | 0 companies |
| Elizabeth Elizabeta Grön Basanic | Deputy Board Member | 0 companies |
| Brizita Birgitta Basanic Taltavull | Chairman | 0 companies |
| Francisco Gustav Taltavull | Board of Directors | 0 companies |